Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Arrowhead Pharmaceuticals (ARWR) Cash from Operations (2016 - 2025)

Arrowhead Pharmaceuticals' Cash from Operations history spans 16 years, with the latest figure at 13481000.0 for Q4 2025.

For Q4 2025, Cash from Operations rose 109.22% year-over-year to 13481000.0; the TTM value through Dec 2025 reached 339305000.0, up 169.07%, while the annual FY2025 figure was 179552000.0, 138.79% up from the prior year.
Cash from Operations reached 13481000.0 in Q4 2025 per ARWR's latest filing, down from 20491000.0 in the prior quarter.
In the past five years, Cash from Operations ranged from a high of 460053000.0 in Q1 2025 to a low of 154720000.0 in Q2 2025.
Average Cash from Operations over 5 years is 17480250.0, with a median of 46489500.0 recorded in 2021.
Peak YoY movement for Cash from Operations: surged 1056.58% in 2021, then tumbled 455.51% in 2024.
A 5-year view of Cash from Operations shows it stood at 61308000.0 in 2021, then dropped by 23.17% to 75516000.0 in 2022, then crashed by 56.05% to 117840000.0 in 2023, then fell by 24.13% to 146272000.0 in 2024, then soared by 109.22% to 13481000.0 in 2025.
Per Business Quant, the three most recent readings for ARWR's Cash from Operations are 13481000.0 (Q4 2025), 20491000.0 (Q3 2025), and 154720000.0 (Q2 2025).